Biofrontera AG Announced Eenrollment of First Patient in Phase I Safety Study Evaluating Photodynamic Therapy with Three Tubes of Ameluz

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.